お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
985015

ポイントオブケア検査(POCT)の世界市場:診断セグメント、モード、エンドユーザー、地域別、COVID-19の影響、100社の企業プロファイル、2026年までの予測

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, End Users, Regions), Impact of COVID-19, 100 Company Profiles - Forecast to 2026

出版日: | 発行: iGate Research Pvt Ltd | ページ情報: 英文 223 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.37円
ポイントオブケア検査(POCT)の世界市場:診断セグメント、モード、エンドユーザー、地域別、COVID-19の影響、100社の企業プロファイル、2026年までの予測
出版日: 2021年01月28日
発行: iGate Research Pvt Ltd
ページ情報: 英文 223 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポイントオブケア検査(POCT)市場は、2026年までに450億米ドルを超えると予測されています。早期の病気の診断と予防についての意識の高まりは、がんや感染症を早期に検出するためのポイントオブケア検査の需要を刺激しています。

また、インドや中国などの新興諸国における感染症や心血管疾患や糖尿病などの慢性疾患の発生率の上昇は、ポイントオブケア検査サービスの需要に影響を与えています。国際糖尿病連合(IDF)によると、2019年の時点で世界における20~79歳の約4億6,300万人が糖尿病を患っています。この数は2045年までに7億人に達すると推定されています。したがって、感染症と慢性疾患の増加は、近い将来、同市場の成長を加速させると考えられています。

当レポートは、世界のポイントオブケア検査(POCT)市場について調査しており、市場規模や予測、シェア、成長要因および課題、診断セグメント・モード・エンドユーザー・地域別の市場分析、競合情勢、100社に及ぶ主要企業のプロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 COVID-19の影響

第3章 世界市場と予測(2010-2026)

第4章 世界市場シェアと予測(2010-2026)

  • 診断セグメント別
  • モード別
  • エンドユーザー別
  • 地域別

第5章 市場分析:診断セグメント別(2010-2026)

  • 血糖値
  • 心臓マーカー
  • 脂質パネル/コレステロール
  • 凝固
  • 感染症
  • 尿
  • 薬物乱用
  • 便潜血
  • 妊娠と不妊
  • 腫瘍マーカー
  • クリティカルケア
  • HbA1c
  • 臨床化学
  • ビリルビン
  • 血液

第6章 市場分析:モード別(2010-2026)

  • 処方箋ベース
  • OTCベース

第7章 市場分析:エンドユーザー別(2010-2026)

  • 病院
  • クリニック
  • 研究所
  • アシスティッドリビングヘルスケア施設
  • 在宅ケア

第8章 市場分析:地域別(2010-2026)

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 企業プロファイル

  • Abbott Laboratories
  • Siemens Healthineers
  • Roche Diagnostics
  • Quest Diagnostics
  • Becton, Dickinson and Company
  • ACON Laboratories
  • Abaxis, Inc
  • Abingdon Health, Ltd
  • Access Bio, Inc.
  • AccuBioTech Co, Ltd.
  • Akers Biosciences, Inc.
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • AmniSure International
  • Aquila Diagnostic Systems, Inc
  • ARKRAY Inc
  • Artron Laboratories Inc.
  • Ascensia Diabetes Care Holdings AG
  • Ativa Medical Corporation
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Augurix Diagnostics
  • Autobio Diagnostics Co., Ltd
  • Axxin
  • Beckman Coulter, Inc
  • Bhat Bio-Tech India Private Ltd.
  • bioLytical Laboratories
  • BioMedomics, Inc
  • Biomerica, Inc.
  • bioMerieux SA
  • Biophor Diagnostics, Inc
  • Bio-Rad Laboratories Inc.
  • Bioscan Screening Systems, Inc.
  • Biosensia Ltd.
  • BTNX Inc.
  • Boditech Med Inc
  • Xiamen Boson Biotech Co. Ltd
  • Calypte Biomedical Corporation
  • Cepheid, Inc
  • Chembio Diagnostic Systems, Inc
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Daktari Diagnostics
  • Danaher Corporation
  • Dexcom, Inc
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • DNA Electronics Ltd. (DNAe)
  • EKF Diagnostics Holdings plc
  • ELITechGroup, Inc.
  • Eurolyser Diagnostica GmbH
  • Exact Sciences Corporation
  • Exalenz Bioscience Ltd
  • Genedrive plc
  • GeTein BioMedical, Inc.
  • Helena Laboratories
  • Hemosure, Inc.
  • Immunostics, Inc.
  • Instrumentation Laboratory
  • JAL Innovation PTE LTD
  • Jant Pharmacal Corporation
  • LamdaGen Corporation
  • LifeScan, Inc
  • LifeSign, LLC
  • MBio Diagnostics, Inc (Now LightDeck Diagnostics)
  • Medix Biochemica
  • Medtronic, Inc
  • A. Menarini Diagnostics S.R.L.
  • Meridian Bioscience, Inc
  • Nano-Ditech Corporation
  • Noble Medical, Inc
  • Nova Biomedical, Corp.
  • Oasis Diagnostics Corporation
  • OPKO Health, Inc
  • OPTI Medical Systems, Inc
  • OraSure Technologies, Inc
  • Polymed Therapeutics Inc.
  • Preventis GmbH
  • Princeton Biomeditech Corporation
  • QuantuMDx Group Limited
  • Radiometer Medical A/S
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics LLC
  • Siloam Biosciences, Inc
  • Sysmex Corporation
  • TECHLAB, Inc.
  • Teco Diagnostics
  • Trinity Biotech PLC
  • Trividia Health
  • Tulip Diagnostics Ltd
  • Veredus Laboratories PTE Ltd
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen

第10章 市場成長要因

  • ポイントオブケア検査:未来への一歩
  • 慢性および感染症の高い有病率
  • セルフテストを含むポイントオブケアの継続的な拡大

第11章 市場の課題

  • 低・中所得国におけるポイントオブケア(POC)検査の障壁
    • POCテクノロジーの採用とスケールアップの障壁
    • 技術的、管理的および運用上の障壁
    • 医療制度関連の障壁
    • 経済的障壁
  • ポリシー/規制ガイドラインと資金調達の課題
  • POC診断開発におけるインフラストラクチャの障壁と課題
図表

List of Figures

  • Figure 3-1: Global - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 3-2: Global - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 5-1: Global - Blood Glucose Testing Market (Million US$), 2010 - 2020
  • Figure 5-2: Global - Forecast for Blood Glucose Testing Market (Million US$), 2021 - 2026
  • Figure 5-3: Global - Cardiac Marker Testing Market (Million US$), 2010 - 2020
  • Figure 5-4: Global - Forecast for Cardiac Marker Testing Market (Million US$), 2021 - 2026
  • Figure 5-5: Global - Lipid Panel/Cholesterol Testing Market (Million US$), 2010 - 2020
  • Figure 5-6: Global - Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2021 - 2026
  • Figure 5-7: Global - Coagulation Testing Market (Million US$), 2010 - 2020
  • Figure 5-8: Global - Forecast for Coagulation Testing Market (Million US$), 2021 - 2026
  • Figure 5-9: Global - Infectious Disease Testing Market (Million US$), 2010 - 2020
  • Figure 5-10: Global - Forecast for Infectious Disease Testing Market (Million US$), 2021 - 2026
  • Figure 5-11: Global - Urinalysis Testing Market (Million US$), 2010 - 2020
  • Figure 5-12: Global - Forecast for Urinalysis Testing Market (Million US$), 2021 - 2026
  • Figure 5-13: Global - Drug of Abuse Testing Market (Million US$), 2010 - 2020
  • Figure 5-14: Global - Forecast for Drug of Abuse Testing Market (Million US$), 2021 - 2026
  • Figure 5-15: Global - Fecal Occult Blood Testing Market (Million US$), 2010 - 2020
  • Figure 5-16: Global - Forecast for Fecal Occult Blood Testing Market (Million US$), 2021 - 2026
  • Figure 5-17: Global - Pregnancy & Fertility Testing Market (Million US$), 2010 - 2020
  • Figure 5-18: Global - Forecast for Pregnancy & Fertility Testing Market (Million US$), 2021 - 2026
  • Figure 5-19: Global - Tumor Marker Testing Market (Million US$), 2010 - 2020
  • Figure 5-20: Global - Forecast for Tumor Marker Testing Market (Million US$), 2021 - 2026
  • Figure 5-21: Global - Critical Care Testing Market (Million US$), 2010 - 2020
  • Figure 5-22: Global - Forecast for Critical Care Testing Market (Million US$), 2021 - 2026
  • Figure 5-23: Global - HbA1c Testing Market (Million US$), 2010 - 2020
  • Figure 5-24: Global - Forecast for HbA1c Testing Market (Million US$), 2021 - 2026
  • Figure 5-25: Global - Clinical Chemistry Testing Market (Million US$), 2010 - 2020
  • Figure 5-26: Global - Forecast for Clinical Chemistry Testing Market (Million US$), 2021 - 2026
  • Figure 5-27: Global - Bilirubin Testing Market (Million US$), 2010 - 2020
  • Figure 5-28: Global - Forecast for Bilirubin Testing Market (Million US$), 2021 - 2026
  • Figure 5-29: Global - Hematology Testing Market (Million US$), 2010 - 2020
  • Figure 5-30: Global - Forecast for Hematology Testing Market (Million US$), 2021 - 2026
  • Figure 6-1: Global - Prescription-based Testing Market (Million US$), 2010 - 2020
  • Figure 6-2: Global - Forecast for Prescription-based Testing Market (Million US$), 2021 - 2026
  • Figure 6-3: Global - OTC-based Testing Market (Million US$), 2010 - 2020
  • Figure 6-4: Global - Forecast for OTC-based Testing Market (Million US$), 2021 - 2026
  • Figure 7-1: Hospitals - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 7-2: Hospitals - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 7-3: Clinics - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 7-4: Clinics - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 7-5: Laboratories - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 7-6: Laboratories - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 7-7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 7-8: Assisted Living Healthcare Facilities - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 7-9: Home Care - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 7-10: Home Care - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 8-1: North America - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 8-2: North America - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 8-3: Europe - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 8-4: Europe - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 8-5: Asia Pacific - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 8-6: Asia Pacific - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 8-7: Latin America - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 8-8: Latin America - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 8-9: Middle East and Africa - Point of Care Testing Market (Million US$), 2010 - 2020
  • Figure 8-10: Middle East and Africa - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
  • Figure 9-1: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2019
  • Figure 9-2: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2020 - 2026
  • Figure 9-3: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2019
  • Figure 9-4: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2020 - 2026
  • Figure 9-5: Roche Diagnostics - Global Sales (Million US$), 2013 - 2019
  • Figure 9-6: Roche Diagnostics - Forecast for Global Sales (Million US$), 2020 - 2026
  • Figure 9-7: Quest Diagnostics - Net Sales (Million US$), 2014 - 2019
  • Figure 9-8: Quest Diagnostics - Forecast for Net Sales (Million US$), 2020 - 2026
  • Figure 9-9: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2020
  • Figure 9-10: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2021 - 2026

List of Tables:

  • Table 4-1: By Diagnostics Segment - Point of Care Testing Market Share (Percent), 2010 - 2020
  • Table 4-2: By Diagnostics Segment - Forecast for Point of Care Testing Market Share (Percent), 2021 - 2026
  • Table 4-3: By Mode - Point of Care Testing Market Share (Percent), 2010 - 2020
  • Table 4-4: By Mode - Forecast for Point of Care Testing Market Share (Percent), 2021 - 2026
  • Table 4-5: By End Users - Point of Care Testing Market Share (Percent), 2010 - 2020
  • Table 4-6: By End Users - Forecast for Point of Care Testing Market Share (Percent), 2021 - 2026
  • Table 4-7: By Region - Point of Care Testing Market Share (Percent), 2010 - 2020
  • Table 4-8: By Region - Forecast for Point of Care Testing Market Share (Percent), 2021 - 2026
  • Table 9-1: Eurolyser Diagnostica GmbH - Point-of-Care Test Portfolio
  • Table 11-1: POCT - Barriers to Adoption and Scale-up of POC Technologies
目次

The global point of care testing (POCT) market is predicted to exceed US$ 45 Billion by 2026. POC testing appears to be headed for a bigger role in diagnosis and monitoring patient care. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Furthermore, growing awareness about early disease diagnosis and prevention has stimulated the demand of point of care testing for detection of cancer and infectious disease at early stages. Rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services. As per the International Diabetes Federation (IDF), around 463 million people aged between 20-79 years had diabetes in 2019 globally. This number is estimated to reach 700 million by 2045. Hence, growing infectious diseases and chronic conditions will enhance the point of care testing market in the near future.

Impact of COVID-19 on Global Point of Care Testing Market

The COVID-19 outbreak has become a global stress test. The disease has infected over 92 Million people worldwide. Globally the death toll has reached 1,974,201 according to the latest statistics from the Worldometers (as of January 13, 2021). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak has created a sense of urgency and panic among people globally. While people are being advised to stay indoors, healthcare professionals and researchers have registered a state of urgency. In this scenario, the point-of-care diagnostics forms the crux of increased testing. Manufacturers in the point-of-care testing market are focusing on developing novel technologies for maximum testing within a minimum period. The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. Development and production in maximum numbers is the need of the hour. Therefore, quick FDA approvals are proving to be the cherry on the cake for the growth of the point-of-care testing market.

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment. Increasing prevalence of diabetes in developing as well as developed economies and the rising inclination of patients towards home testing is the major driver that will drive segmental growth over the forecast timeframe. Cardiac marker segment is expected to grow at the highest rate during the forecast period. The growing prevalence of cardiovascular ailments, increasing purchasing power, rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas is expected to drive the market for cardiac markers. The goal of POC infectious disease testing is to detect pathogens in humans and determine a course of antimicrobial treatment that is most appropriate for the patient. Blood Coagulation and Clinical Chemistry segment is competing closely with each other to grab maximum share of the pie.

By Mode - Global Point of Care Testing Market & Forecast

On the basis of mode, the point of care testing market is dominated by OTC-based testing segment. OTC tests do not require dedicated space as clinical laboratory, and even their turn around time is quick. The Prescription based testing segment is expected to grow at the highest rate during the forecast period.

By End Users - Global Point of Care Testing Market & Forecast

Based on end users, the point of care testing market is segmented into Hospitals, Clinics, Laboratories, Home Care and Assisted Living Healthcare Facilities. Hospitals held majority of the point of care testing market, followed by Clinics. Increase in prevalence of chronic conditions such as cancer and cardiovascular diseases that require proper monitoring and prefer minimally invasive procedures are carried out in hospitals and clinics. The home care segment is expected to grow at the highest rate during the forecast period driven by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

By Region - Global Point of Care Testing Market & Forecast

The point of care testing market, by region, is dominated by North America and is expected to maintain its position throughout the forecast period. This can be attributed to rising prevalence of chronic disorders and infectious diseases, which need portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives to support the adoption of POCT in this region. Europe held second highest share of the point of care testing market. Asia-Pacific point of care testing market is expected to grow at the fastest rate during the forecast period driven by growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies.

iGATE RESEARCH report titled "Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, End Users, Regions), Impact of COVID-19, 100 Company Profiles - Forecast to 2026" provides a comprehensive analysis of the Global Point of Care Testing Market.

This 223 Page report with 66 Figures and 10 Tables has been analyzed from 9 View Points:

  • 1) Global - Point of Care Testing Market & Forecast (2010 - 2026)
  • 2) Impact of COVID-19 on Global Point of Care Testing Market
  • 3) Global - Point of Care Testing Market Share and Forecast (2010 - 2026)
  • 4) By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2026)
  • 5) By Mode - Global Point of Care Testing Market & Forecast (2010 - 2026)
  • 6) By End Users - Global Point of Care Testing Market & Forecast (2010 - 2026)
  • 7) By Region - Global Point of Care Testing Market & Forecast (2010 - 2026)
  • 8) Global Point of Care Testing Market - 100 Company Profiles
  • 9) Global Point of Care Testing Market - Growth Drivers & Challenges

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

  • 1. Blood Glucose Testing
  • 2. Cardiac Marker Testing
  • 3. Lipid Panel/Cholesterol Testing
  • 4. Coagulation Testing
  • 5. Infectious Disease Testing
  • 6. Urinalysis Testing
  • 7. Drug of Abuse Testing
  • 8. Fecal Occult Blood Testing
  • 9. Pregnancy & Fertility Testing
  • 10. Tumor Marker Testing
  • 11. Critical Care Testing
  • 12. HbA1c Testing
  • 13. Clinical Chemistry Testing
  • 14. Bilirubin Testing
  • 15. Hematology Testing

By Mode - Global Point of Care Testing Market & Forecast

  • Prescription-based Testing
  • OTC-based Testing

By End Users - Global Point of Care Testing Market & Forecast

  • 1. Hospitals
  • 2. Clinics
  • 3. Laboratories
  • 4. Assisted Living Healthcare Facilities
  • 5. Home Care

By Region - Global Point of Care Testing Market & Forecast

  • 1. North America
  • 2. Europe
  • 3. Asia Pacific
  • 4. Latin America
  • 5. Middle East & Africa

Global Point of Care Testing Market - 100 Company Profiles

  • 1. Abbott Laboratories
  • 2. Siemens Healthineers
  • 3. Roche Diagnostics
  • 4. Quest Diagnostics
  • 5. Becton, Dickinson and Company
  • 6. ACON Laboratories
  • 7. Abaxis, Inc
  • 8. Abingdon Health, Ltd
  • 9. Access Bio, Inc.
  • 10. AccuBioTech Co, Ltd.
  • 11. Akers Biosciences, Inc.
  • 12. Alfa Scientific Designs, Inc
  • 13. American Bio Medica Corporation
  • 14. AmniSure International
  • 15. Aquila Diagnostic Systems, Inc
  • 16. ARKRAY Inc
  • 17. Artron Laboratories Inc.
  • 18. Ascensia Diabetes Care Holdings AG
  • 19. Ativa Medical Corporation
  • 20. Atlas Link Biotech Co., Ltd
  • 21. Audit Diagnostics
  • 22. Augurix Diagnostics
  • 23. Autobio Diagnostics Co., Ltd
  • 24. Axxin
  • 25. Beckman Coulter, Inc
  • 26. Bhat Bio-Tech India Private Ltd.
  • 27. bioLytical Laboratories
  • 28. BioMedomics, Inc
  • 29. Biomerica, Inc.
  • 30. bioMerieux SA
  • 31. Biophor Diagnostics, Inc
  • 32. Bio-Rad Laboratories Inc.
  • 33. Bioscan Screening Systems, Inc.
  • 34. Biosensia Ltd.
  • 35. BTNX Inc.
  • 36. Boditech Med Inc
  • 37. Xiamen Boson Biotech Co. Ltd
  • 38. Calypte Biomedical Corporation
  • 39. Cepheid, Inc
  • 40. Chembio Diagnostic Systems, Inc
  • 41. Clarity Diagnostics, LLC
  • 42. Confirm Biosciences
  • 43. CTK Biotech, Inc.
  • 44. Daktari Diagnostics
  • 45. Danaher Corporation
  • 46. Dexcom, Inc
  • 47. DIALAB GmbH
  • 48. DiaSys Diagnostic Systems GmbH
  • 49. Diazyme Laboratories, Inc.
  • 50. DNA Electronics Ltd. (DNAe)
  • 51. EKF Diagnostics Holdings plc
  • 52. ELITechGroup, Inc.
  • 53. Eurolyser Diagnostica GmbH
  • 54. Exact Sciences Corporation
  • 55. Exalenz Bioscience Ltd
  • 56. Genedrive plc
  • 57. GeTein BioMedical, Inc.
  • 58. Helena Laboratories
  • 59. Hemosure, Inc.
  • 60. Immunostics, Inc.
  • 61. Instrumentation Laboratory
  • 62. JAL Innovation PTE LTD
  • 63. Jant Pharmacal Corporation
  • 64. LamdaGen Corporation
  • 65. LifeScan, Inc
  • 66. LifeSign, LLC
  • 67. MBio Diagnostics, Inc (Now LightDeck Diagnostics)
  • 68. Medix Biochemica
  • 69. Medtronic, Inc
  • 70. A. Menarini Diagnostics S.R.L.
  • 71. Meridian Bioscience, Inc
  • 72. Nano-Ditech Corporation
  • 73. Noble Medical, Inc
  • 74. Nova Biomedical, Corp.
  • 75. Oasis Diagnostics Corporation
  • 76. OPKO Health, Inc
  • 77. OPTI Medical Systems, Inc
  • 78. OraSure Technologies, Inc
  • 79. Polymed Therapeutics Inc.
  • 80. Preventis GmbH
  • 81. Princeton Biomeditech Corporation
  • 82. QuantuMDx Group Limited
  • 83. Radiometer Medical A/S
  • 84. Response Biomedical Corp
  • 85. Reszon Diagnostics International Sdn. Bhd.
  • 86. Samsung Healthcare
  • 87. Savyon Diagnostics
  • 88. Sekisui Diagnostics LLC
  • 89. Siloam Biosciences, Inc
  • 90. Sysmex Corporation
  • 91. TECHLAB, Inc.
  • 92. Teco Diagnostics
  • 93. Trinity Biotech PLC
  • 94. Trividia Health
  • 95. Tulip Diagnostics Ltd
  • 96. Veredus Laboratories PTE Ltd
  • 97. Vircell
  • 98. WAMA Diagnostica
  • 99. Wave 80 Biosciences
  • 100. Werfen

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

  • Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
  • Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Point of Care Testing Market

3. Global - Point of Care Testing Market & Forecast (2010 - 2026)

4. Global - Point of Care Testing Market Share & Forecast (2010 - 2026)

  • 4.1 By Diagnostics Segment - Global Point of Care Testing Market Share & Forecast
  • 4.2 By Mode - Global Point of Care Testing Market Share & Forecast
  • 4.3 By End Users - Global Point of Care Testing Market Share & Forecast
  • 4.4 By Region - Point of Care Testing Market Share & Forecast

5. By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2026)

  • 5.1 Blood Glucose Testing Market & Forecast
  • 5.2 Cardiac Marker Testing Market & Forecast
  • 5.3 Lipid Panel/Cholesterol Testing Market & Forecast
  • 5.4 Coagulation Testing Market & Forecast
  • 5.5 Infectious Disease Testing Market & Forecast
  • 5.6 Urinalysis Testing Market & Forecast
  • 5.7 Drug of Abuse Testing Market & Forecast
  • 5.8 Fecal Occult Blood Testing Market & Forecast
  • 5.9 Pregnancy & Fertility Testing Market & Forecast
  • 5.10 Tumor Marker Testing Market & Forecast
  • 5.11 Critical Care Testing Market & Forecast
  • 5.12 HbA1c Testing Market & Forecast
  • 5.13 Clinical Chemistry Testing Market & Forecast
  • 5.14 Bilirubin Testing Market & Forecast
  • 5.15 Hematology Testing Market & Forecast

6. By Mode - Global Point of Care Testing Market & Forecast (2010 - 2026)

  • 6.1 Prescription-based Testing Market & Forecast
  • 6.2 OTC-based Testing Market & Forecast

7. By End Users - Global Point of Care Testing Market & Forecast (2010 - 2026)

  • 7.1 Hospitals - Point of Care Testing Market & Forecast
  • 7.2 Clinics - Point of Care Testing Market & Forecast
  • 7.3 Laboratories - Point of Care Testing Market & Forecast
  • 7.4 Assisted Living Healthcare Facilities - Point of Care Testing Market & Forecast
  • 7.5 Home Care - Point of Care Testing Market & Forecast

8. By Region - Global Point of Care Testing Market & Forecast (2010 - 2026)

  • 8.1 North America - Point of Care Testing Market & Forecast
  • 8.2 Europe - Point of Care Testing Market & Forecast
  • 8.3 Asia Pacific - Point of Care Testing Market & Forecast
  • 8.4 Latin America - Point of Care Testing Market & Forecast
  • 8.5 Middle East and Africa - Point of Care Testing Market & Forecast

9. Point of Care Testing Market - Company Profiles

  • 9.1 Abbott Laboratories
    • 9.1.1 Company Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Financial Insight
    • 9.1.4 Business Strategy
  • 9.2 Siemens Healthineers
    • 9.2.1 Company Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Financial Insight
    • 9.2.4 Business Strategy
  • 9.3 Roche Diagnostics
    • 9.3.1 Company Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Financial Insight
    • 9.3.4 Business Strategy
  • 9.4 Quest Diagnostics
    • 9.4.1 Company Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Financial Insight
    • 9.4.4 Business Strategy
  • 9.5 Becton, Dickinson and Company
    • 9.5.1 Company Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Financial Insight
    • 9.5.4 Business Strategy
  • 9.6 ACON Laboratories
    • 9.6.1 Company Overview
    • 9.6.2 Product Portfolio
  • 9.7 Abaxis, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Product Portfolio
  • 9.8 Abingdon Health, Ltd.
    • 9.8.1 Company Overview
    • 9.8.2 Product Portfolio
  • 9.9 Access Bio, Inc.
    • 9.9.1 Company Overview
  • 9.10 AccuBioTech Co, Ltd.
  • 9.11 Akers Biosciences, Inc.
  • 9.12 Alfa Scientific Designs, Inc
  • 9.13 American Bio Medica Corporation
  • 9.14 AmniSure International
  • 9.15 Aquila Diagnostic Systems, Inc
  • 9.16 ARKRAY Inc
  • 9.17 Artron Laboratories Inc.
  • 9.18 Ascensia Diabetes Care Holdings AG
  • 9.19 Ativa Medical Corporation
  • 9.20 Atlas Link Biotech Co., Ltd
  • 9.21 Audit Diagnostics
  • 9.22 Augurix Diagnostics
  • 9.23 Autobio Diagnostics Co., Ltd
  • 9.24 Axxin
  • 9.25 Beckman Coulter, Inc
  • 9.26 Bhat Bio-Tech India Private Ltd. (BBI)
  • 9.27 bioLytical Laboratories
  • 9.28 BioMedomics, Inc
  • 9.29 Biomerica, Inc.
  • 9.30 bioMerieux SA
  • 9.31 Biophor Diagnostics, Inc
  • 9.32 Bio-Rad Laboratories Inc162
  • 9.33 Bioscan Screening Systems, Inc162
  • 9.34 Biosensia Ltd.
  • 9.35 BTNX Inc.
  • 9.36 Boditech Med Inc
  • 9.37 Xiamen Boson Biotech Co. Ltd
  • 9.38 Calypte Biomedical Corporation
  • 9.39 Cepheid, Inc
  • 9.40 Chembio Diagnostic Systems, Inc
  • 9.41 Clarity Diagnostics, LLC
  • 9.42 Confirm Biosciences
  • 9.43 CTK Biotech, Inc.
  • 9.44 Daktari Diagnostics
  • 9.45 Danaher Corporation
  • 9.46 Dexcom, Inc
  • 9.47 DIALAB GmbH
  • 9.48 DiaSys Diagnostic Systems GmbH
  • 9.49 Diazyme Laboratories, Inc.
  • 9.50 DNA Electronics Ltd. (DNAe)
  • 9.51 EKF Diagnostics Holdings plc
  • 9.52 ELITechGroup, Inc.
  • 9.53 Eurolyser Diagnostica GmbH
  • 9.54 Exact Sciences Corporation
  • 9.55 Exalenz Bioscience Ltd.
  • 9.56 Genedrive plc
  • 9.57 GeTein BioMedical, Inc.
  • 9.58 Helena Laboratories
  • 9.59 Hemosure, Inc.
  • 9.60 Immunostics, Inc.
  • 9.61 Instrumentation Laboratory
  • 9.62 JAL Innovation PTE LTD
  • 9.63 Jant Pharmacal Corporation
  • 9.64 LamdaGen Corporation
  • 9.65 LifeScan, Inc
  • 9.66 LifeSign, LLC
  • 9.67 MBio Diagnostics, Inc (Now LightDeck Diagnostics)
  • 9.68 Medix Biochemica
  • 9.69 Medtronic, Inc.
  • 9.70 A. Menarini Diagnostics S.R.L.
  • 9.71 Meridian Bioscience, Inc
  • 9.72 Nano-Ditech Corporation
  • 9.73 Noble Medical, Inc
  • 9.74 Nova Biomedical, Corp.
  • 9.75 Oasis Diagnostics Corporation
  • 9.76 OPKO Health, Inc
  • 9.77 OPTI Medical Systems, Inc
  • 9.78 OraSure Technologies, Inc
  • 9.79 Polymed Therapeutics Inc.
  • 9.80 Preventis GmbH
  • 9.81 Princeton Biomeditech Corporation
  • 9.82 QuantuMDx Group Limited
  • 9.83 Radiometer Medical A/S
  • 9.84 Response Biomedical Corp
  • 9.85 Reszon Diagnostics International Sdn. Bhd.
  • 9.86 Samsung Healthcare
  • 9.87 Savyon Diagnostics
  • 9.88 Sekisui Diagnostics LLC
  • 9.89 Siloam Biosciences, Inc
  • 9.90 Sysmex Corporation
  • 9.91 TECHLAB, Inc.
  • 9.92 Teco Diagnostics
  • 9.93 Trinity Biotech PLC
  • 9.94 Trividia Health
  • 9.95 Tulip Diagnostics Ltd
  • 9.96 Veredus Laboratories PTE Ltd
  • 9.97 Vircell
  • 9.98 WAMA Diagnostica
  • 9.99 Wave 80 Biosciences
  • 9.100 Werfen

10. Global Point of Care Testing Market - Growth Drivers

  • 10.1 Point-of-care Testing: A Step to the Future
  • 10.2 High Prevalence of Chronic and Infectious Diseases
  • 10.3 Continued Expansion of Point of Care Including Self Testing
    • 10.3.1 The Promise of Point-of-Care Testing
    • 10.3.2 Future of Point of Care Testing - The 'Worried Well'
    • 10.3.3 Hub and Spoke
    • 10.3.4 Education

11. Global Point of Care Testing Market - Challenges

  • 11.1 Point of Care (POC) Testing Barriers in Low & Middle-Income Countries
    • 11.1.1 Barriers to Adoption & Scale-up of POC Technologies
    • 11.1.2 Technical, Administrative & Operational Barriers of Point of Care Tests
    • 11.1.3 Health System Related Barriers of Point of Care Tests
    • 11.1.4 Economic Barriers of Point of Care Tests
  • 11.2 Policy/Regulatory Guidelines and Funding Challenges
  • 11.3 Infrastructure Barriers and Challenges with POC Diagnostics Development
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.